Here, we provide the first evidence of improved healthspan and age-related survival with a therapeutic mAb by demonstrating that treatment with an IGF-1R antagonist in older mice significantly and preferentially improves several indices of healthspan, reduced death from neoplastic disease, and increased mean and median lifespan in females
A provider who stays current with the latest research can design a treatment plan that aligns with established safety guidelines, ensuring you get the benefits of the therapy while managing any potential risks
This information is crucial for researchers designing controlled experiments
they are being studied as metabolic medications that may affect outcomes in hormone-sensitive disease
Is this in Scotland
Methods Enzymol 559:127139 Shao Y, Xue C, Liu W, Zuo S, Wei P, Huang L, Lian J, Xu Z (2022) High-level secretory production of leghemoglobin in Pichia pastoris through enhanced globin expression and heme biosynthesis